GRI Bio, Inc.GRIEarnings & Financial Report

Nasdaq · Health Care · Pharmaceutical Preparations

Deep AnalysisCompare

GRI Bio, Inc. is a clinical-stage biopharmaceutical firm developing innovative targeted therapies for autoimmune, inflammatory, and fibrotic diseases. Its product candidates address unmet medical needs, serving global healthcare markets to deliver improved outcomes for patients with underserved disease indications.